The present invention relates to methods, systems, and devices that emit light energy in the ruminant rumenoreticulum, to inactivate a quantity of microbes. The device is a size or shape that will obtain a predetermined position within the rumenoreticulum, and protectively contains long lasting battery power, electric components, and light sources that emit wavelengths that inactivate and destroy microbes. The device, the system and the method according to the present invention also allow detection of biological parameters of the capsule environment and communication with a receiver outside the animal.

Systems and methods are provided for treating or preventing carbon monoxide poisoning. In particular, systems and methods are provided for a phototherapy treatment or prevention system that delivers light radiation to a patient's body to photodissociate carbon monoxide from hemoglobin.

A light irradiating medical device comprising: a shaft extending in a longitudinal axis direction thereof and having a lumen extending in the longitudinal axis direction; a first tubular member disposed in the lumen of the shaft and rotatable about a rotation axis parallel to the longitudinal axis direction of the shaft, the first tubular member having a window located in a part of a peripheral wall of a distal portion; and a light guiding tool disposed in a lumen of the first tubular member and movable in the longitudinal axis direction, the light guiding tool including an optical fiber extending in the longitudinal axis direction, the optical fiber including a core, a cladding coating a radially outer portion of the core, and a cladding-absent portion located at a part of a distal portion of the core, and the window allowing passage therethrough of output light from the light guiding tool.

Devices and systems for impinging light on tissue to induce one or more biological effects and, more particularly, illumination devices and related systems for implementing therapeutic treatments of light are disclosed. Systems may include illumination devices that are configured to provide phototherapy for a variety of medical indications and/or health-related benefits. Illumination devices may be connected to systems that administer and/or monitor multiple illumination devices across multiple geographic regions to compile regional and/or global information related to phototherapeutic usage. Certain aspects relate to system elements, such as local devices and/or servers that are capable of generating treatment protocols for illumination devices based on diagnostic information. After treatment protocols are implemented by illumination devices, administered treatment information along with location information may be provided to the local devices and/or servers.

The present invention provides an optical probe system that allows for determination of optical properties at the wall of a hollow cavity and photosensitizer uptake at the time of photodynamic therapy (PDT). In one embodiment, this system provides for rigorous treatment planning to maximize efficacy and minimize risk to patients by optimizing the concentration of the scattering emulsion infused into the cavity and the delivered laser power.

Systems and method relate to administering phototherapy. A device includes a hollow structure having at least a first open end. The hollow structure includes a rotatable member, one or more coherent light generators, and, for each coherent light generator, one or more lenses or mirrors optically connected to the coherent light generator and configured to alter at least one aspect of a beam of coherent light. The device further includes a processing circuit including a processor and a memory storing instructions. The instructions, when executed by the processor, cause the processor to accept an input from an operator and generate one or more beams of coherent light according to a plurality of settings configured to produce a therapeutic effect at a targeted treatment site. Additionally, the rotatable member is configured to be rotated to direct the one or more beams of coherent light to the targeted treatment site.

A UV light delivery device for performing intra-corporeal ultraviolet therapy is provided. The device includes an elongated body separated by a proximal end and a distal end. The device also includes a UV light source configured to be received at the receiving space. In some examples, the UV light source is configured to emit light with wavelengths with significant intensity between 320 nm and 410 nm and is utilized in conjunction with an endotracheal tube or a nasopharyngeal airway.

Provided herein as a transoral minimally invasive method and a system thereof for the treatment of gastrointestinal diseases and/or obesity, which at least partially encircles a part of the gastrointestinal tract, such as esophagus of the patient by advancing an elongated deformable portion of a neurostimulator assembly endoluminally to the subfascial area from the outer wall of the esophagus and introducing the elongated deformable portion sub-fascially in the subfascial area, whereby at least one part of the encircled esophagus will be modulated using a modulator.

Systems for enabling delivery of very high peak power laser pulses through optical fibers for use in ablation procedures preferably in contact mode. Such lasers advantageously emit at 355 nm wavelength. Other systems enable selective removal of undesired tissue within a blood vessel, while minimizing the risk of damaging the blood vessel itself, based on the use of the ablative properties of short laser pulses of 320 to 400 nm laser wavelength, with selected parameters of the mechanical walls of the tubes constituting the catheter, of the laser fluence and of the force that is applied by the catheter on the tissues. Additionally, a novel method of calibrating such catheters is disclosed, which also enables real time monitoring of the ablation process. Additionally, novel methods of protecting the fibers exit facets are disclosed.

A process for heat treating biological tissue includes providing a plurality of energy emitters formed into an array. Treatment energy in the form of microwave energy is generated from the plurality of emitters and applied to target tissue. The treatment energy has energy and application parameters selected so as to raise the target tissue temperature sufficiently to create a therapeutic effect while maintaining an average temperature of the target tissue over several minutes at or below a predetermined temperature so as not to destroy or permanently damage the target tissue.